Circadian rhythms can influence drugs' effectiveness
Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.
Apr 24, 2024
0
86
Giving drugs at different times of day could significantly affect how they are metabolized in the liver, according to a new study from MIT.
Apr 24, 2024
0
86
As a malignant disease of the liver cells, hepatocellular carcinoma (HCC) is one of the main causes of cancer-related deaths. While the treatment options for this aggressive type of cancer remain limited, the incidence is ...
Apr 23, 2024
0
10
Liver inflammation, a common side-effect of cancers elsewhere in the body, has long been associated with worse cancer outcomes and more recently associated with poor response to immunotherapy. Now, a team led by researchers ...
Apr 19, 2024
0
40
Children with liver transplants must take immunosuppressant medications for life. To maintain tolerance of the transplanted liver, doctors treat transplant rejection and conduct ongoing maintenance immunosuppression by increasing ...
Apr 17, 2024
0
29
Drug-loaded 3D printed films could change cancer treatments forever as world first research from the University of South Australia shows that new films not only kill more than 80% of liver cancer cells but could also significantly ...
Apr 15, 2024
0
94
Innovative carbon beads, invented by researchers at UCL, reduce bad bacteria and inflammation in animal models, which are linked to liver cirrhosis and other serious health issues.
Apr 14, 2024
1
154
In a world-first, QIMR Berghofer scientists have discovered the mechanism that causes severe inflammation among millions of people with chronic liver disease.
Apr 12, 2024
0
15
A new analysis by researchers at UCLA Health found that mortality rates of middle-aged Black Americans caused by the "deaths of despair"—suicide, drug overdose and alcoholic liver disease—surpassed the rate of white Americans ...
Apr 10, 2024
0
37
A custom-made anti-tumor vaccine added to standard immunotherapy was twice as likely to shrink liver cancer as when a patient received immunotherapy alone, a new study shows.
Apr 9, 2024
0
64
Argininosuccinate lyase deficiency (ASLD), also known as argininosuccinic aciduria, is a severe metabolic disease where the body does not process proteins normally, instead resulting in a very dangerous accumulation of argininosuccinic ...
Apr 4, 2024
0
142